Preparation of two kinds of superparamagnetic carriers-supported cis-platinum complexes and the comparison of their characteristics

Chinese Science Bulletin

Volumn 51, Issue 2, 2006, Pages 151-157

  Xie, Minqiang ^a   Chen, Shuaijun ^a   Xu, Xueqing ^a   Li, Zhonghan ^a   Shen, Hui ^a   Xu, Jiarui ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Carriers; Cis platinum; Magnetic nanometer particles; N oleoylsarcosine; Sodium alginate

Indexed keywords

EID: 33748867514     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-005-0633-8     Document Type: Article

References (14)

1. Schurig, J. E., Brander, W. T., Haftalen, J. B. et al., Cisplatin: Current Status and New Development (eds. Prestayko, A. W., Crooke, S. T., Carter, S. K.), New York: Academic Press, 1980.
2. Sasaki, H., Niimi, S., Akiyama, M. et al., Antitumor activity of 13,14-dihydro-15-deoxy-delta7-prostaglandin-A1-methyl ester integrated into lipid microspheres against human ovarian carcinoma cells resistant to cisplatin in vivo, Cancer Res., 1999, 59(16): 3919-3922.
3. Zhang, J. S., Imai, T., Suenaga, A. et al., Molecular-weight-dependent pharmacokinetics and cytotoxic properties of cisplatin complexes prepared with chondroitin sulfate A and C, Int. J. Pharm., 2002, 240(1-2): 23-31.
4. Savic, R., Luo, L., Eisenberg, A. et al., Micellar nanocontainers distribute to defined cytoplasmic organelles, Science, 2003, 300(5619): 615-618.
5. Avichezer, D., Schechter, B., Arnon, R. et al., Functional polymers in drug delivery: carrier-supported CDDP (cis-platin) complexes of polycarboxylates - effect on human ovarian carcinoma, Reactive & Functional Polymers, 1998, 36: 59-69.
6. Alexiou, C., Jurgons, R., Schmid, R. J. et al., Magnetic drug targeting - biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment, J. Drug Target, 2003, 11(3): 139-149.
7. Pan, Y., Li, Y. J., Gao, P. et al., Enhancement of gastrointestinal absorption of chitosan-coated insulin-loaded poly(lactic-co-glycolic acid) nanoparticles, Acta Pharm. Sinica, 2003, 38(6): 467-470.
8. Naiwa, H. S., Handbook of nanostructured material and nanotechnology, Vol. 5, Australia: Academic Press, 2000, 577-604.
9. Schechter, B., Arnon, R., Wilchek, M., Polymers in drug delivery: Immunotargeting of carrier-supported cis-platinum (CDDP) complexes, Reactive Polymers, 1995, 25: 167-175.
10. Xu, X. Q., Shen, H., Xu, J. R. et al., Aqueous-based magnetite magnetic fluids stabilized by surface small micelles of oleolysarcosine, Applied Surface Sciences, 2004, 220: 430-436.
11. Mitra, S., Gaur, U., Ghosh, P. C. et al., Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier, J. Control Release, 2001, 74(1-3): 317-323.
12. Kohori, F., Yokoyama, M., Sakai, K. et al., Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems, J. Control Release, 2002, 78(1-3): 155-163.
13. Moroz, P., Jones, S. K., Winter, J., Targeting liver tumors with hyperthermia: ferromagnetic embolization in a rabbit liver tumor model, J. Surg. Oncol., 2001, 78(1): 22-29.
14. Fitzsimmons, R. J., Ryaby, J. T., Mohan, S. et al., Combined magnetic fields increase insulin-like growth factor-II in TE-85 human osteosarcoma bone cell cultures, Endocrinology, 1995, 136(7): 3100-3106.